McCaw TR - Search Results

1

Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer.

Doo DW, Meza-Perez S, Londoño AI, Goldsberry WN, Katre AA, Boone JD, Moore DJ, Hudson CT, Betella I, McCaw TR, Gangrade A, Bao R, Luke JJ, Yang ES, Birrer MJ, Starenki D, Cooper SJ, Buchsbaum DJ, Norian LA, Randall TD, Arend RC. Doo DW, et al. Among authors: mccaw tr. Ther Adv Med Oncol. 2020 Apr 14;12:1758835920913798. doi: 10.1177/1758835920913798. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32313567 Free PMC article.

2

Modulation of antitumor immunity with histone deacetylase inhibitors.

McCaw TR, Randall TD, Forero A, Buchsbaum DJ. McCaw TR, et al. Immunotherapy. 2017 Dec;9(16):1359-1372. doi: 10.2217/imt-2017-0134. Immunotherapy. 2017. PMID: 29185390 Free PMC article. Review.

3

Overcoming immune suppression with epigenetic modification in ovarian cancer.

McCaw TR, Randall TD, Arend RC. McCaw TR, et al. Transl Res. 2019 Feb;204:31-38. doi: 10.1016/j.trsl.2018.06.003. Epub 2018 Jun 23. Transl Res. 2019. PMID: 30048638 Review.

4

The expression of MHC class II molecules on murine breast tumors delays T-cell exhaustion, expands the T-cell repertoire, and slows tumor growth.

McCaw TR, Li M, Starenki D, Cooper SJ, Liu M, Meza-Perez S, Arend RC, Buchsbaum DJ, Forero A, Randall TD. McCaw TR, et al. Cancer Immunol Immunother. 2019 Feb;68(2):175-188. doi: 10.1007/s00262-018-2262-5. Epub 2018 Oct 17. Cancer Immunol Immunother. 2019. PMID: 30334128 Free PMC article.

5

The antitumor effects of entinostat in ovarian cancer require adaptive immunity.

Smith HJ, McCaw TR, Londono AI, Katre AA, Meza-Perez S, Yang ES, Forero A, Buchsbaum DJ, Randall TD, Straughn JM Jr, Norian LA, Arend RC. Smith HJ, et al. Among authors: mccaw tr. Cancer. 2018 Dec 15;124(24):4657-4666. doi: 10.1002/cncr.31761. Epub 2018 Nov 13. Cancer. 2018. PMID: 30423192 Free PMC article.

6

Revisiting entinostat as an immune-potentiating adjuvant.

McCaw TR, Randall TD, Arend RC. McCaw TR, et al. Oncotarget. 2018 Dec 18;9(99):37278-37279. doi: 10.18632/oncotarget.26453. eCollection 2018 Dec 18. Oncotarget. 2018. PMID: 30647864 Free PMC article. No abstract available.

7

Histone deacetylase inhibition promotes intratumoral CD8⁺ T-cell responses, sensitizing murine breast tumors to anti-PD1.

McCaw TR, Li M, Starenki D, Liu M, Cooper SJ, Arend RC, Forero A, Buchsbaum DJ, Randall TD. McCaw TR, et al. Cancer Immunol Immunother. 2019 Dec;68(12):2081-2094. doi: 10.1007/s00262-019-02430-9. Epub 2019 Nov 12. Cancer Immunol Immunother. 2019. PMID: 31720815 Free PMC article.

8

Class I histone deacetylase inhibition promotes CD8 T cell activation in ovarian cancer.

McCaw TR, Goel N, Brooke DJ, Katre AA, Londoño AI, Smith HJ, Randall TD, Arend RC. McCaw TR, et al. Cancer Med. 2021 Jan;10(2):709-717. doi: 10.1002/cam4.3337. Epub 2020 Dec 24. Cancer Med. 2021. PMID: 33369199 Free PMC article.

9

Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance.

McCaw TR, Inga E, Chen H, Jaskula-Sztul R, Dudeja V, Bibb JA, Ren B, Rose JB. McCaw TR, et al. Oncologist. 2021 Apr;26(4):e608-e621. doi: 10.1002/onco.13627. Epub 2021 Jan 2. Oncologist. 2021. PMID: 33284507 Free PMC article. Review.

10

Sarcoma in patients with Lynch syndrome and response to immunotherapy.

Shehata MS, Lofftus SY, Park JY, Singh AS, Federman NC, Eilber FC, Crompton JG, McCaw TR. Shehata MS, et al. Among authors: mccaw tr. J Surg Oncol. 2024 Mar;129(4):820-826. doi: 10.1002/jso.27567. Epub 2023 Dec 27. J Surg Oncol. 2024. PMID: 38151827

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page